Dhaka, Bangladesh (BBN) – The board of directors of Ambee Pharmaceuticals Limited has recommended 26 percent cash dividend, said an official disclosure on Wednesday.
The dividend was given for the 18 months period from January 01, 2015 to June 30, 2016, the disclosure added.
The final approval will come during the annual general meeting (AGM) of the pharmaceuticals company scheduled to be held at 10am in Dhaka on December 29.
The record date for entitlement of dividend is on December 14.
The company has reported earnings per share (EPS) of BDT 3.41 and net operating cash flow per share (NOCFPS) of BDT 12.06 for the 18 months period from January 01, 2015 to June 30, 2016.
The company has also reported earnings EPS of BDT 2.71 and NOCFPS of BDT 11.59 for the 12 months period from January 01, 2015 to December 31, 2015 whereas BDT 0.70, and BDT 0.47 respectively for the 6 months period from January 01, 2016 to June 30, 2016.
Net asset value (NAV) per share of BDT 24.82 as of June 30, 2016 while BDT 24.12 as of December 31, 2015.
The will be no price limit on the trading of the shares of the company today following its corporate declaration.
Each share of the pharma company, which was listed on the Dhaka bourse in 1986, closed at Tk 435.60 on Tuesday.
The company’s paid-up capital is BDT 25 million and authorised capital is BDT 24 million, while total number of securities is 2,400,000, according to statistics from the DSE.
The sponsor-directors own 75.26 percent stake in the company, while institutional investors 5.46 percent, and the general public19.28 per cent as on October 31, 2016.